Literature DB >> 18652934

New indications for antepartum testing: making the case for antepartum surveillance or timed delivery for women of advanced maternal age.

Ruth C Fretts1, Ugonna A Duru.   

Abstract

Maternal age is an independent risk factor for stillbirth; a moderate number of these occur in normally formed babies near term. For a woman 40 years of age or older giving birth, her risk of having a chromosomal anomaly is 1/66. What is not appreciated is that even without medical risk factors, her risk of having a stillbirth after 37 weeks of gestation is 1/116. This article reviews the risks and benefits of the strategy of antepartum testing and timed delivery and discusses the limitations of the available data in this field.

Entities:  

Mesh:

Year:  2008        PMID: 18652934     DOI: 10.1053/j.semperi.2008.04.016

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  4 in total

1.  Gestational age-specific neonatal morbidity among pregnancies complicated by advanced maternal age: a population-based retrospective cohort study.

Authors:  Amy M Valent; Tondra Newman; Aimin Chen; Amy Thompson; Emily DeFranco
Journal:  J Matern Fetal Neonatal Med       Date:  2015-06-05

2.  Prepregnancy risk factors for antepartum stillbirth in the United States.

Authors:  Uma M Reddy; S Katherine Laughon; Liping Sun; James Troendle; Marian Willinger; Jun Zhang
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

3.  A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers.

Authors:  Samantha C Lean; Rebecca L Jones; Stephen A Roberts; Alexander E P Heazell
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-20       Impact factor: 3.007

4.  Risk factors for antepartum stillbirth and the influence of maternal age in New South Wales Australia: a population based study.

Authors:  Adrienne Gordon; Camille Raynes-Greenow; Kevin McGeechan; Jonathan Morris; Heather Jeffery
Journal:  BMC Pregnancy Childbirth       Date:  2013-01-16       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.